Minireview serum inhibitors of interleukin-2

Eugene J. Kucharz, James Goodwin

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Interleukin-2 (IL-2) is an important modulator of cell-mediated immunity. Its activity is suppressed by various serum inhibitors generated under normal and pathological conditions. It is believed that an inhibitor which occurs in normal serum is a T-cell derived heat labile protein (or protein-glycolipid complex), and it acts in a homeostatic mechanism to restict IL-2 action to the vicinity of the activated T cells. Changes in inhibitory activity have been found in various physiological and pathological states, e.g. during ontogeny, in systemic lupus erythematosus, in rheumatoid arthritis, and with some systemic infections. There are also suggestions that some tumor cells generate IL-2 inhibitors which diminish killer cell activity against the tumor. It is possible that a better understanding of IL-2 inhibitors would help elucidate some pathological mechanisms connected with disturbed cellular immune responses.

Original languageEnglish (US)
Pages (from-to)1485-1491
Number of pages7
JournalLife Sciences
Volume42
Issue number16
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

T-cells
Cellular Immunity
Interleukin-2
Tumors
T-Lymphocytes
Glycolipids
Serum
Systemic Lupus Erythematosus
Modulators
Rheumatoid Arthritis
Neoplasms
Proteins
Hot Temperature
Cells
Infection
interleukin 2 inhibitor

ASJC Scopus subject areas

  • Pharmacology

Cite this

Minireview serum inhibitors of interleukin-2. / Kucharz, Eugene J.; Goodwin, James.

In: Life Sciences, Vol. 42, No. 16, 1988, p. 1485-1491.

Research output: Contribution to journalArticle

Kucharz, Eugene J. ; Goodwin, James. / Minireview serum inhibitors of interleukin-2. In: Life Sciences. 1988 ; Vol. 42, No. 16. pp. 1485-1491.
@article{9d8cb28141004813877e7673d53f968b,
title = "Minireview serum inhibitors of interleukin-2",
abstract = "Interleukin-2 (IL-2) is an important modulator of cell-mediated immunity. Its activity is suppressed by various serum inhibitors generated under normal and pathological conditions. It is believed that an inhibitor which occurs in normal serum is a T-cell derived heat labile protein (or protein-glycolipid complex), and it acts in a homeostatic mechanism to restict IL-2 action to the vicinity of the activated T cells. Changes in inhibitory activity have been found in various physiological and pathological states, e.g. during ontogeny, in systemic lupus erythematosus, in rheumatoid arthritis, and with some systemic infections. There are also suggestions that some tumor cells generate IL-2 inhibitors which diminish killer cell activity against the tumor. It is possible that a better understanding of IL-2 inhibitors would help elucidate some pathological mechanisms connected with disturbed cellular immune responses.",
author = "Kucharz, {Eugene J.} and James Goodwin",
year = "1988",
doi = "10.1016/0024-3205(88)90004-5",
language = "English (US)",
volume = "42",
pages = "1485--1491",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "16",

}

TY - JOUR

T1 - Minireview serum inhibitors of interleukin-2

AU - Kucharz, Eugene J.

AU - Goodwin, James

PY - 1988

Y1 - 1988

N2 - Interleukin-2 (IL-2) is an important modulator of cell-mediated immunity. Its activity is suppressed by various serum inhibitors generated under normal and pathological conditions. It is believed that an inhibitor which occurs in normal serum is a T-cell derived heat labile protein (or protein-glycolipid complex), and it acts in a homeostatic mechanism to restict IL-2 action to the vicinity of the activated T cells. Changes in inhibitory activity have been found in various physiological and pathological states, e.g. during ontogeny, in systemic lupus erythematosus, in rheumatoid arthritis, and with some systemic infections. There are also suggestions that some tumor cells generate IL-2 inhibitors which diminish killer cell activity against the tumor. It is possible that a better understanding of IL-2 inhibitors would help elucidate some pathological mechanisms connected with disturbed cellular immune responses.

AB - Interleukin-2 (IL-2) is an important modulator of cell-mediated immunity. Its activity is suppressed by various serum inhibitors generated under normal and pathological conditions. It is believed that an inhibitor which occurs in normal serum is a T-cell derived heat labile protein (or protein-glycolipid complex), and it acts in a homeostatic mechanism to restict IL-2 action to the vicinity of the activated T cells. Changes in inhibitory activity have been found in various physiological and pathological states, e.g. during ontogeny, in systemic lupus erythematosus, in rheumatoid arthritis, and with some systemic infections. There are also suggestions that some tumor cells generate IL-2 inhibitors which diminish killer cell activity against the tumor. It is possible that a better understanding of IL-2 inhibitors would help elucidate some pathological mechanisms connected with disturbed cellular immune responses.

UR - http://www.scopus.com/inward/record.url?scp=0023672638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023672638&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(88)90004-5

DO - 10.1016/0024-3205(88)90004-5

M3 - Article

C2 - 3280939

AN - SCOPUS:0023672638

VL - 42

SP - 1485

EP - 1491

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 16

ER -